Follow the 휴온스 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 휴온스 has published 57 reports. Market capitalisation: €293bn. The latest transaction was filed on 16 March 2026 (Other). Among the most active insiders: 윤인상. The full history is accessible without an account.
57
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
17 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,131 of 29,063 companies
70.5
score / 100
Value
85
Quality
56
FCF yld7.1%
Earn yld15%
EV/EBITDA5.8x
ROE7.9%
Gross mgn45%
Net mgn6.9%
Debt/EBITDA2.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
휴온스 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development of innovative pharmaceutical and healthcare products.